Elicio Therapeutics, Inc. (ELTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 121.89M |
| Enterprise Value | 117.84M |
| P/E Ratio | -1.36 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -40.56 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.77 |
| Return On Equity | -27.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.13M |
| EBITDA | -37.31M |
| Net Income | -39.57M |
| Diluted EPS | -2.58 |
| Total Cash | 14.95M |
| Total Cash/Share | 0.82 |
| Total Debt | 14.34M |
| Total Debt/Equity | -9.98 |
| Current Ratio | 2.24 |
| Book Value Per Share | -0.08 |
| 52-Week Change | -65.59 |
| 52-Week High | 16 |
| 52-Week Low | 2.66 |
| Moving Average 50 Days | 8.05 |
| Moving Average 200 Days | 9.26 |
| Average Volume | 1.66M |
| Shares Outstanding | 19.07M |
| % Held by Institutions | 17.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 02, 2023 |